Recombinant Human LASS5 Protein，GST

LASS5, or Longevity Assurance Homolog 5, is a member of the LASS gene family that plays a crucial role in sphingolipid metabolism and cellular signaling. Research on LASS5 has gained prominence due to its involvement in various biological processes, including cell proliferation, differentiation, and apoptosis, which are vital for maintaining cellular homeostasis. Dysregulation of LASS5 has been linked to several diseases, including cancer and neurodegenerative disorders, highlighting its potential as a therapeutic target. The reconstitution of LASS5 as a recombinant protein allows for detailed studies of its functional properties, enzymatic activities, and interactions within cellular pathways. Understanding the structure-function relationship of this protein is essential for uncovering its role in health and disease. Furthermore, recombinant LASS5 can be utilized in drug discovery processes, enabling the identification of small molecules that can modulate its activity. This research could pave the way for innovative therapeutic strategies aimed at targeting sphingolipid metabolism, offering new avenues for the treatment of various pathological conditions. Overall, the study of LASS5 and its associated recombinant protein holds significant promise for advancing our understanding of cellular mechanisms and developing novel therapeutic interventions.